Search results for "pancreatic"

showing 10 items of 545 documents

End-Stage Pancreatic Adenocarcinoma Presenting as a Sister Mary Joseph's Nodule.

2017

[No abstract available]

Malemedicine.medical_specialtyFatal outcomeSkin NeoplasmsAdenocarcinomaDiagnosis Differential03 medical and health sciences0302 clinical medicineFatal OutcomeX ray computedMedicineHumansStage (cooking)Sister Mary Joseph's NoduleNeoplasm StagingUmbilicusbusiness.industryGeneral MedicineMiddle Agedmedicine.diseasePancreatic Neoplasms030220 oncology & carcinogenesisAdenocarcinoma030211 gastroenterology & hepatologyNeoplasm stagingRadiologybusinessTomography X-Ray Computedpancreatic adenocarcinoma sister Mary Joseph's noduleBiomarkersThe American surgeon
researchProduct

Interleukin-6 gene promoter –174G/C polymorphism and insulin resistance: a pilot study

2007

Background: The aim of this pilot study was to evaluate the relationship between interleukin-6 promoter -174G/C (IL-6 -174G/C) polymorphism and insulin resistance (IR) in obese patients with coronary heart disease (CHD). Methods: Twenty obese male patients with CHD were selected from a larger database of patients (n=606). IL-6 -174G/C genotype was previously analysed and only homozygotes with the CC genotype (n=10) or GG genotype (n=10) were selected. IR was measured using the homeostasis model assessment for IR (HOMA-IR) method. Results: Differences in age, body mass index, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol (HDL-C), triglyceride (T…

Malemedicine.medical_specialtyGenotypemedicine.medical_treatmentClinical BiochemistryCoronary DiseasePilot ProjectsBiologychemistry.chemical_compoundInsulin resistanceRisk FactorsPolymorphism (computer science)Internal medicineGenotypemedicineHumansObesityPromoter Regions GeneticPancreatic hormoneAgedPolymorphism GeneticTriglycerideInterleukin-6InsulinCholesterol HDLBiochemistry (medical)Age Factorsnutritional and metabolic diseasesGeneral MedicineMiddle Agedmedicine.diseaseObesityEndocrinologychemistryCardiovascular DiseasesFemaleInsulin ResistanceBody mass indexClinical Chemical Laboratory Medicine
researchProduct

The basic structural lesion of persistent neonatal hypoglycaemia with hyperinsulinism: deficiency of pancreatic D cells or hyperactivity of B cells?

1984

Pancreatic tissue obtained at subtotal pancreatectomy from 15 infants with persistent hypoglycaemia with hyperinsulinism, and autopsy specimens from 23 age-matched normoglycaemic controls, were studied with morphometric methods after immunocytochemical staining of the four main islet cell types (A, B, D and pancreatic polypeptide cells). In three cases, a focal lesion was detected by gross examination. Macroscopic or microscopic examination did not distinguish the 12 other cases from controls. As found previously, nesidioblastosis was not a specific feature of the pancreas in infantile hypoglycaemia, being observed in age-matched controls as well. In cases with hypoglycaemia the volume dens…

Malemedicine.medical_specialtyPancreatic Polypeptide-Secreting CellsCell typePathologyEndocrinology Diabetes and MetabolismNesidioblastosisCell CountLesionIslets of LangerhansInternal medicineHyperinsulinismInternal MedicinemedicineHumansB cellCell Nucleusbusiness.industryDegranulationInfant NewbornInfantmedicine.diseaseHypoglycemiaEndocrinologymedicine.anatomical_structureFemalemedicine.symptombusinessPancreasHyperinsulinismDiabetologia
researchProduct

Use of famotidine in severe exocrine pancreatic insufficiency with persistent maldigestion on enzymatic replacement therapy. A long-term study in cys…

1992

In patients with pancreatic exocrine insufficiency, the use of pancreatic enzyme does not abolish steatorrhea in some cases. We carried out a long-term prospective study in an attempt to clarify the effectiveness of the associated use of famotidine to enzymatic supplementation on fat absorption and nutritional parameters of patients with pancreatic insufficiency due to cystic fibrosis. We studied 10 patients, mean age 12.5 years, with persistent steatorrhea on enzymatic supplementation. A double-blind crossover design was used and famotidine (1 mg/kg/day) or placebo was given as adjuvant to enzymatic preparations for either of two six-month periods. A statistically significative reduction i…

Malemedicine.medical_specialtyPancreatic diseaseAdolescentCystic FibrosisPhysiologyGrowthPlaceboCystic fibrosisGastroenterologyInternal medicinemedicineHumansProspective StudiesAdverse effectExocrine pancreatic insufficiencyChildbusiness.industryGastroenterologymedicine.diseaseFamotidineCrossover studySteatorrheaFamotidineCeliac DiseaseEndocrinologyPancreatinExocrine Pancreatic InsufficiencyFemalemedicine.symptombusinessmedicine.drugDigestive diseases and sciences
researchProduct

Role of pancreatic impairment in growth recovery during gluten-free diet in childhood celiac disease

1997

Abstract BACKGROUND & AIMS: Clinical significance and duration of insufficient release of pancreatic enzymes in childhood celiac disease have not been clarified. The aim of this study was to evaluate the role that pancreatic impairment plays in growth recovery and the duration of this impairment. METHODS: Forty-six patients with celiac disease who had a median age of 2.5 years were enrolled. Fecal chymotrypsin level was determined at diagnosis and then every 15 days after the beginning of a gluten-free diet in all patients. RESULTS: At diagnosis, 17 of 46 patients with celiac disease had subnormal fecal chymotrypsin values. During the gluten-free diet, a progressive reduction in the percent…

Malemedicine.medical_specialtyPancreatic diseaseGlutensGastroenterologyCoeliac diseaseImmunopathologyInternal medicineChymotrypsinHumansMedicineClinical significanceChildPancreaschemistry.chemical_classificationChymotrypsinHepatologybiologybusiness.industryBody WeightGastroenterologyInfantnutritional and metabolic diseasesmedicine.diseaseGlutenDietCeliac DiseaseEl NiñochemistryChild Preschoolbiology.proteinFemaleGluten freebusinessGastroenterology
researchProduct

Pancreatic dysfunction and its association with fat malabsorption in HIV infected children

1998

Background—Nutrient malabsorption frequently occurs in HIV infected children, but very few studies have investigated exocrine pancreatic digestive capacity in these cases.Aims—To investigate pancreatic function in HIV infected children and to determine whether faecal fat loss, a prominent feature of intestinal dysfunction, is associated with pancreatic dysfunction.Patients—Forty seven children with HIV infection without apparent pancreatic disease and 45 sex and age matched healthy controls.Methods—Pancreatic function was evaluated by measuring elastase 1 concentration and chymotrypsin activity in stools by ELISA and colorimetric methods, respectively. Intestinal function was evaluated by m…

Malemedicine.medical_specialtyPancreatic diseaseMalabsorptionAdolescentEnzyme-Linked Immunosorbent AssayHIV InfectionsBiologyGastroenterologyIntestinal absorptionCoeliac diseaseFecesMalabsorption SyndromesInternal medicinemedicineChymotrypsinHumansProspective StudiesChildPancreatic elastasePancreatic ElastasePancreas and Biliary TractGastroenterologyInfantPancreatic Diseasesmedicine.diseaseDietary FatsFat malabsorptionSteatorrheaCeliac Diseasemedicine.anatomical_structureIntestinal AbsorptionCase-Control StudiesChild PreschoolFemalemedicine.symptomPancreasGut
researchProduct

Chemoradioimmunotherapy with 5-fluorouracil, cisplatin and interferon-α in pancreatic and periampullary cancer: Results of a feasibility study

2008

Abstract Background Recent studies give rise to the hypothesis, that adjuvant chemoradioimmunotherapy with 5-fluorouracil (5-FU), cisplatin and interferon-α (IFN-α) might be a possible new treatment of pancreatic cancer in resected patients. We report the up-to-now experience at our institution. Patients and methods Eleven patients with histological diagnosis of localized carcinoma of the pancreas ( n  = 7) or periampullary ( n  = 4) were prospectively analyzed. Four patients were deemed unresectable because of local invasion of adjacent organs (neoadjuvant setting) and seven patients underwent curative resection (adjuvant setting). Eight patients were classified as T3 carcinomas and three …

Malemedicine.medical_specialtyPancreatic diseasemedicine.medical_treatmentAntineoplastic AgentsRisk AssessmentGastroenterology03 medical and health sciences0302 clinical medicineInternal medicinePancreatic cancermedicinePeriampullary cancerHumansNeoplasm InvasivenessRadiology Nuclear Medicine and imagingSurvival rateNeoplasm Staging030304 developmental biology0303 health sciencesbusiness.industryPatient SelectionRadiotherapy Dosagemedicine.diseaseCombined Modality Therapypeople.cause_of_deathRecombinant Proteins3. Good healthSurgeryPancreatic NeoplasmsSurvival RateRadiation therapyOncology030220 oncology & carcinogenesisConcomitantInterferon Type IFeasibility StudiesFemaleFluorouracilImmunotherapyCisplatinbusinesspeopleChemoradiotherapyProgressive diseaseCancer/Radiothérapie
researchProduct

Recurrence of Acute Gallstone Pancreatitis and Relationship with Cholecystectomy or Endoscopic Sphincterotomy

2004

To determine the prevalence of recurrence of gallstone pancreatitis, its clinical features, and the presence of prognostic factors of recurrence.From January 1, 2000 to August 31, 2003, 233 patients admitted with acute gallstone pancreatitis (AGP) were prospectively studied. Patients were divided into two groups: recurrent and nonrecurrent group. Clinical, analytical, radiological, prognostic parameters, and severity (Atlanta criteria) were assessed, along with the performance of cholecystectomy or endoscopic sphincterotomy (ES). Clinical features of recurrence were analyzed. Univariate (chi(2), Student's t-test) and multivariate tests were performed. Statistical significance was assumed if…

Malemedicine.medical_specialtyPancreatic diseasemedicine.medical_treatmentGallstonesSeverity of Illness IndexSphincterotomy EndoscopicRecurrenceRisk FactorsSeverity of illnessPrevalenceHumansMedicineCholecystectomyProspective StudiesProspective cohort studyAgedChi-Square DistributionHepatologymedicine.diagnostic_testbusiness.industryGallbladderGeneral surgeryGastroenterologyMiddle AgedPrognosismedicine.diseaseSurgeryEndoscopyLogistic Modelsmedicine.anatomical_structurePancreatitisAcute DiseasePancreatitisFemaleCholecystectomybusinessChi-squared distributionThe American Journal of Gastroenterology
researchProduct

Pancreatic insufficiency in celiac disease is not dependent on nutritional status

1994

To determine the relationship between pancreatic secretory capacity and nutritional status in celiac patients, we studied 52 patients with celiac disease (24 males, 28 females; age range 6-36 months) and 30 healthy control subjects (14 males, 16 females; age range 6-42 months). A secretin-cerulein test was performed on all patients, and levels of serum albumin and plasma fibronectin were assayed. In addition, weight/height ratios were calculated in the celiacs, who were then divided into three groups on this basis, as follows: celiacs with weight/height ratioor = 3rd percentile; those with weight/height ratio between the 4th and 10th percentiles; and those with weight/height ratio10th perce…

Malemedicine.medical_specialtyPercentilePhysiologyBiopsySerum albuminNutritional StatusDiseaseStatistics NonparametricPathogenesisSecretinInternal medicineIntestine SmallmedicineHumansProspective StudiesLipaseChi-Square DistributionbiologyChemistryGastroenterologyAlbuminInfantNutritional statusHepatologyCeliac DiseasePancreatic Function TestsEndocrinologyChild Preschoolbiology.proteinExocrine Pancreatic InsufficiencyFemaleCeruletideDigestive Diseases and Sciences
researchProduct

Surgical treatment of pancreatic cancer

1984

From 1964 to 1982, there were 782 patients treated for carcinoma of the pancreas. In 174 patients pancreaticoduodenal resection was possible (22%). Until 1977 we performed Whipple procedures, while from 1978 to 1982 total pancreatectomy was preferred. Comparing the results of both methods, we did not find any advantages of total pancreatectomy. Operative mortality did not decrease, survival time did not extend, and the higher resection rates (up to 26%) for more advanced tumor stages were accompanied by greater morbidity. With respect to the patients with inoperable cancer of the pancreas, we found over the last 5 years that the rate of those not undergoing surgery has climbed from 8% to 25…

Malemedicine.medical_specialtyPercutaneousDuodenumbusiness.industryExploratory laparotomyMortality ratemedicine.medical_treatmentAnastomosisPrognosismedicine.diseaseSurgeryPancreatic NeoplasmsPancreatectomyCardiothoracic surgeryPancreatic cancermedicineCarcinomaHumansFemaleSurgerybusinessNeoplasm StagingAbdominal surgeryWorld Journal of Surgery
researchProduct